NUTRALIFE BIOSCIENCES, INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2013 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Nutralife Biosciences, Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2013 to Q3 2022.
  • Nutralife Biosciences, Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2022 was -$1.18M, a 71.2% decline year-over-year.
  • Nutralife Biosciences, Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2022 was -$3.99M, a 33.3% increase year-over-year.
  • Nutralife Biosciences, Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$5.83M, a 102% decline from 2020.
  • Nutralife Biosciences, Inc annual Net Income (Loss) Attributable to Parent for 2020 was -$2.89M, a 27.9% increase from 2019.
  • Nutralife Biosciences, Inc annual Net Income (Loss) Attributable to Parent for 2019 was -$4.01M, a 93.2% decline from 2018.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$3.99M -$1.18M -$490K -71.2% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-21
Q2 2022 -$3.5M -$900K +$910K +50.3% Apr 1, 2022 Jun 30, 2022 10-Q 2022-11-21
Q1 2022 -$4.41M -$1.08M +$1.42M +56.7% Jan 1, 2022 Mar 31, 2022 10-Q 2022-11-21
Q4 2021 -$5.83M -$827K +$153K +15.6% Oct 1, 2021 Dec 31, 2021 10-K 2022-04-11
Q3 2021 -$5.98M -$688K -$116K -20.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-21
Q2 2021 -$5.86M -$1.81M -$1.49M -470% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-21
Q1 2021 -$4.37M -$2.5M -$1.48M -145% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-21
Q4 2020 -$2.89M -$980K +$256K +20.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-11
Q3 2020 -$3.15M -$572K +$355K +38.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$3.5M -$318K +$238K +42.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$3.74M -$1.02M +$269K +20.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
Q4 2019 -$4.01M -$1.24M -$716K -138% Oct 1, 2019 Dec 31, 2019 10-K 2021-06-24
Q3 2019 -$3.29M -$927K -$210K -29.3% Jul 1, 2019 Sep 30, 2019 10-Q 2021-05-12
Q2 2019 -$3.08M -$556K -$333K -150% Apr 1, 2019 Jun 30, 2019 10-Q 2021-05-12
Q1 2019 -$2.75M -$1.29M -$674K -110% Jan 1, 2019 Mar 31, 2019 10-Q 2021-05-12
Q4 2018 -$2.07M -$520K -$93.3K -21.9% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-19
Q3 2018 -$1.98M -$717K +$7.81M +91.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$9.79M -$223K +$9.96M +97.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-14
Q1 2018 -$19.7M -$614K +$3.88M +86.3% Jan 1, 2018 Mar 31, 2018 10-Q/A 2019-05-17
Q4 2017 -$23.6M -$427K Oct 1, 2017 Dec 31, 2017 10-K/A 2019-04-03
Q3 2017 -$8.53M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$10.2M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$4.49M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q3 2015 -$2.54M -$780K -$280K -56.1% Jul 1, 2015 Sep 30, 2015 10-Q 2015-12-17
Q2 2015 -$2.26M -$501K +$37.5K +6.96% Apr 1, 2015 Jun 30, 2015 10-Q 2015-09-04
Q1 2015 -$2.3M -$502K -$222K -79.3% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-15
Q4 2014 -$2.08M -$757K -$292K -62.8% Oct 1, 2014 Dec 31, 2014 10-K/A 2015-04-29
Q3 2014 -$1.78M -$500K +$103K +17% Jul 1, 2014 Sep 30, 2014 10-Q 2015-12-17
Q2 2014 -$1.89M -$538K +$388K +41.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-09-04
Q1 2014 -$2.27M -$280K -$191K -214% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$2.08M -$465K Oct 1, 2013 Dec 31, 2013 10-K/A 2015-04-29
Q3 2013 -$603K Jul 1, 2013 Sep 30, 2013 10-Q/A 2014-11-19
Q2 2013 -$926K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 -$89.2K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.